Is human cytomegalovirus infection associated with hypertension? the united states national health and nutrition examination survey 1999-2002

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Li, Chao ^a   Samaranayake, Nithushi R ^a   Ong, Kwok Leung ^b   Wong, Hoi Kin ^a   Cheung, Bernard M Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE SURVEY; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; POPULATION RESEARCH; RACE DIFFERENCE; SEROPREVALENCE; SEX DIFFERENCE; UNITED STATES; AGE; BLOOD; CLINICAL TRIAL; CYTOMEGALOVIRUS; INFORMATION PROCESSING; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; RISK FACTOR; SEXUAL DEVELOPMENT; VIROLOGY;

HUMAN HERPESVIRUS 5;

ADOLESCENT; ADULT; AGE FACTORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DATA COLLECTION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; UNITED STATES;

EID: 84863621393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039760     Document Type: Article

References (29)

1. Cheung BMY, Ong KL, (2011) The Challenge of Managing Hypertension. In: Finkel ML, Westport CT, editors. pp. 117-128 editors. Public health in the 21st century. Praeger Press.
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS, (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49: 69-75.
3. Chaturvedi S, (2004) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): is it really practical? Natl Med J India 17: 227.
4. Taal HR, Verwoert GC, Demirkan A, Janssens AC, Rice K, et al. (2012) Genome-Wide Profiling of Blood Pressure in Adults and Children. Hypertension 59: 241-247.
5. Crough T, Khanna R, (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22: 76-98, Table of Contents.
6. Bate SL, Dollard SC, Cannon MJ, (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 50: 1439-1447.
7. Martin JM, Danziger-Isakov LA, (2011) Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation. Pediatr Transplant 15: 229-236.
8. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, et al. (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6: e16103.
9. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, et al. (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108: 678-683.
10. Kyto V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, et al. (2005) Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis 40: 683-688.
11. Grahame-Clarke C, (2005) Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 12: 42-45.
12. Danesh J, Collins R, Peto R, (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436.
13. Zhang M, Yang Y, Yang X, Cai J, (2011) Human cytomegalovirus infection is a novel etiology for essential hypertension. Med Hypotheses 76: 682-684.
14. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS): National Health and Nutrition Examination Survey questionnaire, examination protocol and laboratory protocol. Hyattsville, Maryland: United States Department of Health and Human Services, Centers for Disease Control and Prevention, 1999-2002. Available:http://www.cdc.gov/nchs/nhanes.htm. Accessed 2011 Nov 30.
15. Cui JS, Hopper JL, Harrap SB, (2003) Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 41: 207-210.
16. Haarala A, Kahonen M, Lehtimaki T, Aittoniemi J, Jylhava J, et al. (2012) Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 167: 309-316.
17. Shen YH, Zhang L, Utama B, Wang J, Gan Y, et al. (2006) Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovascular Research 69: 502-511.
18. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, et al. (2004) Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 109: 500-505.
19. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, et al. (2004) Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 110: II207-212.
20. Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, et al. (2008) NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82: 4250-4256.
21. Wong WT, Wong SL, Tian XY, Huang Y, (2010) Endothelial Dysfunction: The Common Consequence in Diabetes and Hypertension. Journal of Cardiovascular Pharmacology 55: 300-307.
22. Savoia C, Schiffrin EL, (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clinical Science 112: 375-384.
23. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, et al. (1996) The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70: 7569-7579.
24. Fuhrmann S, Streitz M, Reinke P, Volk HD, Kern F, (2008) T cell response to the cytomegalovirus major capsid protein (UL86) is dominated by helper cells with a large polyfunctional component and diverse epitope recognition. J Infect Dis 197: 1455-1458.
25. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, et al. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460.
26. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M, (2011) Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovascular Research.
27. Li S, Zhu J, Zhang W, Chen Y, Zhang K, et al. (2011) Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124: 175-184.
28. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, et al. (2009) Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 5: e1000427.
29. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, et al (2000) Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87: 1195-1201.